Dominik Wolf, Director of the University Clinic for Hematology and Oncology in Innsbruck, emphasizes the importance of colonoscopy as the gold standard for colorectal cancer screening and advocates for a nationwide screening program in Austria to increase early detection and reduce mortality, especially as younger patients are increasingly affected. #Darmkrebs #Vorsorge #Screening
Auf dem Kongress der American Society of Clinical Oncology in Chicago wurden wegweisende Fortschritte in der Krebsbehandlung vorgestellt, darunter neue zielgerichtete Therapien für Bauchspeicheldrüsenkrebs, schwarze Hautkrebs und Brustkrebs, mit vielversprechenden Ergebnissen, die den Patienten individuellere und weniger belastende Behandlungsmöglichkeiten bieten könnten. #Krebsbehandlung #Bauchspeicheldrüsenkrebs #Therapiefortschritte
Presentati al congresso dell’American Society of Clinical Oncology (ASCO) i dati di fase III su daraxonrasib, farmaco sperimentale contro il tumore al pancreas, che ha dato risultati molto promettenti nei test clinici, con una sopravvivenza superiore a un anno nei pazienti trattati, circa il doppio rispetto alla chemioterapia tradizionale. Il medicinale agisce sulle mutazioni del gene KRAS, presenti nella grande maggioranza dei casi di questo tipo di cancro. Gli esperti sottolineano che non si tratta di una cura definitiva, ma di un importante passo avanti nella ricerca contro uno dei tumori più aggressivi al mondo #ASCO2023 #CancroAlPancreas #RicercaMedica
Nová genové testování pro pacientky s hormonálně pozitivním rakovinou prsu, prezentované na kongresu American Society of Clinical Oncology, by mohlo snížit potřebu chemoterapie tím, že určí, kteří pacienti s nízkým rizikem recidivy mohou tuto léčbu vynechat. #borstkanker #chemotherapie #genetischetesten
Enrique Grande, oncólogo y líder del proyecto 'One Oncology' del grupo QuirónSalud en Madrid, aboga por la creación de una red público-privada para mejorar el tratamiento del cáncer, lo que permitiría a los pacientes recibir atención especializada sin importar el hospital, priorizando siempre su acceso a la mejor opción disponible. #Oncología #Cáncer #SaludPública
Deputy Minister of Development Stavros Kalafatis highlighted that Greece produces a significant portion of Europe's oncology (50%), cardio-metabolic (30%), and penicillin (25%) drugs, emphasizing the importance of collaboration between the state, industry, and research sectors in driving innovation and sustainable growth within the healthcare industry. #InnovationInHealthcare #PharmaceuticalIndustry #ResearchAndDevelopment
RT @RogerSeheult: Steven Kornfeld is a hero. The retired oncologist from Bend, Oregon stepped in when the ship’s doctor became ill on the s… #Hero #Oncology #HealthCare #US
The article by Gina Kolata and Rebecca Robbins highlights a breakthrough in the treatment of pancreatic cancer with daraxonrasib, an experimental drug that significantly extends the lives of patients by targeting the KRAS protein, which contributes to various cancers; after decades of failed attempts to develop therapies for this lethal disease, this breakthrough represents a potential paradigm shift in oncology akin to the advent of immunotherapy. #CancerResearch #PancreaticCancer #DrugDevelopment #US
A recent study published in JAMA Oncology reveals that over half of patients with metastatic lung cancer in the U.S. do not receive potentially life-extending treatments due to various barriers such as late diagnoses, access issues, stigma, and a lack of oncologist consultations, despite the availability of promising new therapies that have significantly improved treatment outcomes for this deadly disease. #LungCancer #CancerTreatment #HealthcareAccess #US #CO #TX
A recent study published in JAMA Oncology reveals that over half of patients with metastatic lung cancer in the U.S. do not receive potentially life-extending treatments, such as chemotherapy and immunotherapy, due to barriers like late diagnosis, access issues, shame, and fatalism, despite the availability of new drugs that have significantly improved treatment options. #LungCancer #CancerTreatment #HealthEquity #US
A study published in JAMA Oncology reveals that more than half of patients with metastatic lung cancer in the U.S. do not receive potentially life-extending treatments due to various barriers such as diagnostic delays, lack of access to oncologists, and social stigma, despite the availability of new drugs that have significantly improved treatment options. #LungCancer #CancerTreatment #HealthEquity #US
A recent study published in JAMA Oncology revealed that over half of patients with metastatic lung cancer, despite the availability of new, effective treatments, do not receive life-extending therapies due to various barriers such as access issues, late diagnoses, stigma, and lack of oncologist consultations, highlighting a significant gap in care for this deadly disease. #LungCancer #CancerTreatment #HealthcareAccess #US
According to the latest research published by "JAMA Oncology," the HPV vaccine in boys reduces the risk of various types of cancer associated with this pathogen by half. (Original: Z najnowszych badań opublikowanych przez „JAMA Oncology” wynika, że szczepionka przeciwko wirusowi HPV u chłopców o połowę zmniejsza ryzyko wystąpienia związanych z tym patogenem różnego typu nowotworów.) #HPVvaccine #CancerPrevention #PublicHealth #Nospecificcountrycodesarementionedinthearticle.
The oncology service at Barbastro Hospital is facing a critical situation marked by delays, a shortage of specialists, and a perceived abandonment by healthcare authorities, prompting the reactivation of the Platform of Affected Oncology Patients, which calls for urgent staffing changes and the reinstatement of a mixed contract model to ensure continuity of care. #OncologyCare #HealthcareCrisis #PatientAdvocacy #ES
2nd Czech PhD bioinformatics conference started in Křelov near Olomouc with the Abdulrahman Kahraman from NW university Basel about how to hit cancer hard with bioinformatics and precision oncology - especially with alternative splicing analysis 🧬💊🖥️ https://t.co/P3LwMQOMUx #Bioinformatics #CancerResearch #PrecisionOncology
Nová globální analýza publikovaná v časopise The Lancet Oncology upozorňuje, že až 28 % případů rakoviny prsu u žen může být spojeno se šesti modifikovatelnými životními návyky, přičemž prevence založená na změně těchto návyků má potenciál snížit incidenci onemocnění, zvláště v chudších zemích, kde dostupnost zdravotní péče výrazně ovlivňuje úmrtnost. #rakovinaprsu #prevence #zivotnistyl
Precision medicine is transforming cancer care, but access remains uneven. Hear from Eric Lander, M.D., Minnesota Oncology, @TheUSONetwork, on how biopharma and community practices can collaborate to make targeted therapies available to every patient: https://t.co/sw4Jyu6FVN. https://t.co/jyR7IZ8jsm -
